Join to access to all OVN content. Join for Free

Results for 'clinical advances'

Recent Advances and Future Directions in Oncology
OVN Avatar Hematologic Oncology Update Podcast
Recent Advances and Future Directions in Oncology

Listen on Everand Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in acute myeloid leukemia, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung c…

Nov 23rd • 364 mins listen

Recent Advances and Real-World Implications in Chronic Lymphocytic Leukemia and Lymphomas
OVN Avatar Hematologic Oncology Update Podcast
Recent Advances and Real-World Implications in Chronic Lymphocytic Leukemia and Lymphomas

Listen on Everand Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas, multiple myeloma, genitourinary cancers, brea…

Mar 4th • 60 mins listen

Recent Advances and Real-World Implications in Multiple Myeloma
OVN Avatar Hematologic Oncology Update Podcast
Recent Advances and Real-World Implications in Multiple Myeloma

Listen on Everand Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas, multiple myeloma, genitourinary cancers,…

Mar 4th • 60 mins listen

Rethinking How We Track and Treat Cancer
Partner Avatar Rebecca Previs
Rethinking How We Track and Treat Cancer

Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker

HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.

Jul 13th • 19 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...